Description

According to StrategyHelix, the global diabetes treatments market is expected to increase by US$ 43.2 billion during 2022-2028, expanding at a CAGR of 6.2% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for diabetes treatments. The global diabetes treatments market is segmented on the basis of product, and region. Based on product, the global diabetes treatments market is categorized into insulin delivery devices, diabetes medications, glucose monitoring devices. Globally, the diabetes medications segment made up the largest share of the diabetes treatments market. Geographically, the global diabetes treatments market is segmented into Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America captured the largest share of the market in 2021.

The glucose monitoring devices market is further segmented into blood glucose test strips (BGTS), blood glucose meters, lancets and lancing devices, and continuous glucose monitoring (CGM) devices. The BGTS segment was the largest contributor to the global diabetes treatments market in 2021. Furthermore, the insulin delivery devices market has been categorized into external insulin pumps, implantable insulin pumps, insulin inhalers, insulin jet injectors, insulin patches, insulin pens and needles, and insulin syringes. The insulin pens and needles segment is estimated to account for the largest share of the global diabetes treatments market. The diabetes medications market is further divided into injectable therapies, and oral antidiabetic drugs (OADs). The injectable therapies segment held the largest share of the global diabetes treatments market in 2021 and is anticipated to hold its share during the forecast period.

The global diabetes treatments market is highly competitive. The prominent players operating in the global diabetes treatments market include Abbott Laboratories, Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), AstraZeneca plc, B. Braun Melsungen AG, Bayer AG, Becton Dickinson and Company (BD), Boston Scientific Corp., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche AG, GSK plc, Insulet Corporation, Johnson & Johnson, LifeScan Inc., Medtronic Inc., Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., Terumo Corporation. Competitive landscape gives a description of the competitive nature of the global diabetes treatments market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the diabetes treatments market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: insulin delivery devices, diabetes medications, glucose monitoring devices
Region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028
Company mentioned: Abbott Laboratories, Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), AstraZeneca plc, B. Braun Melsungen AG, Bayer AG, Becton Dickinson and Company (BD), Boston Scientific Corp., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche AG, GSK plc, Insulet Corporation, Johnson & Johnson, LifeScan Inc., Medtronic Inc., Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., Terumo Corporation

Key Benefits for Stakeholders

– Get a comprehensive picture of the global diabetes treatments market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Diabetes treatments market overview
Part 3. Market breakdown by product
– Insulin delivery devices
– Diabetes medications
– Glucose monitoring devices
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
Part 5. Key companies
– Abbott Laboratories
– Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
– AstraZeneca plc
– B. Braun Melsungen AG
– Bayer AG
– Becton, Dickinson and Company (BD)
– Boston Scientific Corp.
– Danaher Corp.
– Eli Lilly and Co.
– F. Hoffmann-La Roche AG
– GSK plc
– Insulet Corporation
– Johnson & Johnson
– LifeScan, Inc.
– Medtronic Inc.
– Novo Nordisk A/S
– Pfizer Inc.
– Sanofi S.A.
– Terumo Corporation
About StrategyHelix
Disclaimer